杨凯婷
个人概况
杨凯婷律师的执业领域主要集中在香港联合交易所的首次公开发行及其他股权资本市场交易、上市前投资、 公开收购以及上市规则和证券法规合规等。杨律师积极参与处理了一家寻求在香港联交所上市的生物科技 公司的上市前融资和首次公开发行，以及该生物科技公司在香港联交所上市后的监管合规事务，该生物科技公司是新的新兴及创新产业公司上市制度下在香港联交所上市的首家未有盈利的生物科技公司，即歌礼制药（香港联交所：1672）。
Get In Touch
办事处
This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as "Cooley"). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction, and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. When advising companies, our attorney-client relationship is with the company, not with any individual. This content may have been generated with the assistance of artificial intelligence (Al) in accordance with our Al Principles, may be considered Attorney Advertising and is subject to our legal notices.